Medical Devices Investors & VC Firms in United States
1104 firms in this list, with a median first check of $500K. 275 of them lead rounds. Generated from verified public data and updated continuously.
Catalyst Health Ventures
BostonSeed–Series A$1M – $3M
7 people
Easton Capital
New YorkSeed–Series B$10M – $20M
7 people
Virginia Venture Partners
RichmondPre-Seed–Seed$100K
10 people
Claremont Creek Ventures
OaklandPre-Seed–Series A$500K – $3M
6 people
Coddle Creek Capital
KannapolisPre-Seed–Seed$150K – $650K
15 people
Costella Kirsch
Menlo ParkSeed–Growth
6 people
DEFTA Partners
San FranciscoSeed–Series A
11 people
Xcellerant Ventures
ScottsdalePre-Seed–Series A
14 people
Bragiel Brothers
San FranciscoPre-Seed–Growth
2 people
Ballast Point Ventures
TampaGrowth$5M – $15M
12 people
Cardinal Partners
PrincetonSeed–Growth
12 people
Harbor Light Capital Partners
KeeneSeed–Series A$1M – $5M
9 people
Latterell Venture Partners
San RamonSeed–Series A$50K – $10M
6 people
Finchley Healthcare Ventures
MontrealSeed–Series A
15 people
MedScience Ventures
Boston
15 people
Solasta Ventures
BostonSeed–Series B
6 people
Visionary Ventures
Newport BeachSeries A–Late Stage$5M – $15M
9 people
PureTech Health
Boston
14 people
Iyengar Capital Partners
ClaytonSeed–Series B
16 people
Overwater Ventures Llc
Palo AltoPre-Seed–Seed$400K – $2M
7 people
Healthtech Capital
Los Altos HillsPre-Seed–Series A
3 people
Laerdal Million Lives Fund
San FranciscoSeries A–Series B$1M – $5M
9 people
HM Venture Partners
San FranciscoSeed–Growth
7 people
Mutual Capital Partners
WestlakeSeries A–Series C$1M
4 people
Related lists
Investors & VC Firms in North America (13286)Investors & VC Firms in United States (12284)Investors & VC Firms in Europe (6052)AI & Machine Learning Investors & VC Firms (5303)Investors & VC Firms in Global (5278)Fintech Investors & VC Firms (5112)Healthtech Investors & VC Firms (4639)SaaS Investors & VC Firms (4498)Enterprise Software Investors & VC Firms (4394)Crypto & Web3 Investors & VC Firms (4130)
Data sourced from public filings and firms' own websites — see our methodology.




























































































